Phage therapy program
Cytophage Technologies
| Status | Intake unconfirmed |
|---|---|
| Type | Company |
| Location | Winnipeg, Manitoba; Canada |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Company describes physician/hospital-partner individual-patient clinical development; no current general expanded-access application or public patient enrollment route verified. |
|---|---|
| Areas of work | PJI phage supply: historical 2024 case and two S. aureus candidate patients announced September 2025, subject to ethics, Health Canada and Environment Canada approvals. |
| International access | No public international-patient eligibility or acceptance policy verified. |
What to confirm
- Announcement expected treatment in Q4 2025 and follow-up in 2026; actual dosing/current new-patient capacity not verified. Do not present selected candidates as a recruiting trial.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | cytophage |
|---|